{"id":160935,"date":"2026-07-21T10:49:46","date_gmt":"2026-07-21T05:19:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=160935"},"modified":"2026-07-21T10:49:47","modified_gmt":"2026-07-21T05:19:47","slug":"beta-drugs-share-price-soars-q1-results-21-july-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/","title":{"rendered":"Beta Drugs Share Price Soared 17% on Results Day After Q1 FY27 Profit Jumps 41% to Rs 16.49 Crore"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Beta Drugs share price up 0.43% at Rs 2,450, after soaring 17% on results day. Q1 FY27 PAT Rs 16.49 crore, up 41% YoY. Revenue Rs 125.55 crore, up 25.3% YoY.<\/em><\/p>\n<p>The Beta Drugs share price soared over 17 percent on results day after the pharmaceutical company delivered a robust Q1 FY27, with consolidated net profit rising 41 percent year on year to Rs 16.49 crore on the back of 25.3 percent revenue growth to Rs 125.55 crore, extending its gains into trade on 21 July 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#About_Beta_Drugs\" title=\"About Beta Drugs\">About Beta Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Beta_Drugs_Q1_FY27_Results_Key_Numbers\" title=\"Beta Drugs Q1 FY27 Results: Key Numbers\">Beta Drugs Q1 FY27 Results: Key Numbers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Why_Beta_Drugs_Share_Price_Is_Reacting\" title=\"Why Beta Drugs Share Price Is Reacting\">Why Beta Drugs Share Price Is Reacting<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Outlook_for_Beta_Drugs_Share_Price\" title=\"Outlook for Beta Drugs Share Price\">Outlook for Beta Drugs Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#FAQs_on_Beta_Drugs_Q1_FY27_Results\" title=\"FAQs on Beta Drugs Q1 FY27 Results\">FAQs on Beta Drugs Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Why_did_Beta_Drugs_share_price_soar_on_results_day\" title=\"Why did Beta Drugs share price soar on results day?\">Why did Beta Drugs share price soar on results day?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#What_was_Beta_Drugss_Q1_FY27_EPS\" title=\"What was Beta Drugs&#8217;s Q1 FY27 EPS?\">What was Beta Drugs&#8217;s Q1 FY27 EPS?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#What_products_does_Beta_Drugs_manufacture\" title=\"What products does Beta Drugs manufacture?\">What products does Beta Drugs manufacture?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#What_growth_guidance_has_Beta_Drugs_given_for_FY27\" title=\"What growth guidance has Beta Drugs given for FY27?\">What growth guidance has Beta Drugs given for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Why_did_profit_grow_faster_than_revenue_for_Beta_Drugs\" title=\"Why did profit grow faster than revenue for Beta Drugs?\">Why did profit grow faster than revenue for Beta Drugs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Is_Beta_Drugs_share_price_a_buy_after_the_results\" title=\"Is Beta Drugs share price a buy after the results?\">Is Beta Drugs share price a buy after the results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-share-price-soars-q1-results-21-july-2026\/#Where_can_I_track_Beta_Drugs_share_price_live\" title=\"Where can I track Beta Drugs share price live?\">Where can I track Beta Drugs share price live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Beta_Drugs\"><\/span><strong>About Beta Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\">Beta Drugs<\/a> manufactures oncology drugs, contract manufacturing products, and consumer healthcare items, with a growing presence in both domestic and export pharmaceutical markets.<\/p>\n<p>The company has been reporting healthy growth across its branded oncology, contract manufacturing, exports, and consumer healthcare businesses, with management reiterating confidence in delivering 20 to 25 percent consolidated growth during FY27.<\/p>\n<p>Beta Drugs&#8217; diversified pharmaceutical portfolio, spanning specialty oncology to consumer healthcare, gives the Beta Drugs share price multiple growth levers that reduce dependence on any single product category or geography.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Beta_Drugs_Q1_FY27_Results_Key_Numbers\"><\/span><strong>Beta Drugs Q1 FY27 Results: Key Numbers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Consolidated Revenue<\/td>\n<td>Rs 125.55 crore<\/td>\n<td>Up 25.3% YoY from Rs 100.20 crore<\/td>\n<\/tr>\n<tr>\n<td>Profit Before Tax (PBT)<\/td>\n<td>Rs 22.04 crore<\/td>\n<td>Up nearly 41% YoY<\/td>\n<\/tr>\n<tr>\n<td>Profit After Tax (PAT)<\/td>\n<td>Rs 16.49 crore<\/td>\n<td>Up from Rs 11.70 crore YoY<\/td>\n<\/tr>\n<tr>\n<td>Earnings Per Share (EPS)<\/td>\n<td>Rs 14.78<\/td>\n<td>Up from Rs 11.59 YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The Beta Drugs share price rally reflects a quarter where profit grew significantly faster than revenue, with 41 percent PAT growth outpacing 25.3 percent revenue growth, indicating the company is not merely selling more but also improving the quality of its earnings through margin expansion.<\/p>\n<p>Healthy growth across branded oncology, contract manufacturing, exports, and consumer healthcare, as highlighted by management, suggests the improvement is broad based rather than concentrated in a single business line, supporting confidence in the sustainability of this quarter&#8217;s beat.<\/p>\n<p>Management&#8217;s reiteration of its 20 to 25 percent consolidated growth guidance for FY27, alongside reduced finance costs mentioned in company commentary, provides forward looking confirmation that this quarter&#8217;s strength is expected to continue rather than being a one-off spike for the Beta Drugs share price.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Consult a SEBI Registered Investment Advisor on Univest<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Beta_Drugs_Share_Price_Is_Reacting\"><\/span><strong>Why Beta Drugs Share Price Is Reacting<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Beta Drugs share price surge of over 17 percent on results day reflects strong market conviction that the company&#8217;s growth strategy across multiple pharmaceutical segments is gathering momentum, with margin expansion adding further credibility to the growth story.<\/p>\n<p>Reduced finance costs, cited alongside the operational improvements, suggest the company may be benefiting from a stronger balance sheet position, which can support continued investment in capacity and new product development without excessive debt.<\/p>\n<p>The broad based nature of the growth, spanning oncology, contract manufacturing, exports, and consumer healthcare, likely reassured investors that the Beta Drugs share price rally is grounded in genuine operational strength across the business rather than a single product&#8217;s performance.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Outlook_for_Beta_Drugs_Share_Price\"><\/span><strong>Outlook for Beta Drugs Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking the Beta Drugs share price should watch for continued execution against the company&#8217;s stated 20 to 25 percent FY27 growth guidance, since sustaining this pace across multiple quarters would validate the current re-rating.<\/p>\n<p>New product launches and capacity additions in the oncology and contract manufacturing segments will be key catalysts to watch, given these are typically higher margin businesses that could further support profitability.<\/p>\n<p>Export market expansion, particularly for oncology products where India has been gaining global market share, represents an additional growth lever that could extend the Beta Drugs share price momentum beyond the domestic market opportunity.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Beta Drugs share price live and get instant Q1 result alerts.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beta Drugs delivered an exceptional Q1 FY27, with profit growing 41 percent to Rs 16.49 crore on 25.3 percent revenue growth, sending the Beta Drugs share price up over 17 percent on results day. Broad based strength across oncology, contract manufacturing, exports, and consumer healthcare, combined with reiterated FY27 growth guidance, supports a constructive outlook. Investors should track execution consistency and consult a SEBI registered adviser before acting on the Beta Drugs share price.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Beta_Drugs_Q1_FY27_Results\"><\/span><strong>FAQs on Beta Drugs Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Beta_Drugs_share_price_soar_on_results_day\"><\/span><strong>Why did Beta Drugs share price soar on results day?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Beta Drugs share price soared over 17 percent after the company reported Q1 FY27 consolidated net profit up 41 percent year on year to Rs 16.49 crore, on 25.3 percent revenue growth to Rs 125.55 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Beta_Drugss_Q1_FY27_EPS\"><\/span><strong>What was Beta Drugs&#8217;s Q1 FY27 EPS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs reported earnings per share of Rs 14.78 for Q1 FY27, up from Rs 11.59 in Q1 FY26, reflecting the strong profit growth during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_products_does_Beta_Drugs_manufacture\"><\/span><strong>What products does Beta Drugs manufacture?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs manufactures oncology drugs, contract manufacturing products, and consumer healthcare items, serving both domestic and export pharmaceutical markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_growth_guidance_has_Beta_Drugs_given_for_FY27\"><\/span><strong>What growth guidance has Beta Drugs given for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Management reiterated confidence in delivering 20 to 25 percent consolidated growth during FY27, supported by healthy growth across all its business segments in Q1.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_profit_grow_faster_than_revenue_for_Beta_Drugs\"><\/span><strong>Why did profit grow faster than revenue for Beta Drugs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Profit grew 41 percent, faster than the 25.3 percent revenue growth, indicating margin expansion, supported by reduced finance costs mentioned alongside the results.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Beta_Drugs_share_price_a_buy_after_the_results\"><\/span><strong>Is Beta Drugs share price a buy after the results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not constitute investment advice. While the results were strong, investors should evaluate valuation after the sharp rally and consult a SEBI registered adviser before acting on the Beta Drugs share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Beta_Drugs_share_price_live\"><\/span><strong>Where can I track Beta Drugs share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track the Beta Drugs share price live on the Univest app and website, along with quarterly result alerts and research on pharmaceutical stocks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beta Drugs share price soared 17% on results day after Q1 FY27 consolidated net profit rose 41% YoY to Rs 16.49 crore on 25.3% revenue growth this quarter.<\/p>\n","protected":false},"author":34,"featured_media":160957,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-160935","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784611189:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Beta Drugs Share Price Soared 17% on Strong Q1 Results"],"rank_math_description":["Beta Drugs share price soared 17% on results day after Q1 FY27 consolidated net profit rose 41% YoY to Rs 16.49 crore on 25.3% revenue growth this quarter."],"rank_math_focus_keyword":["Beta Drugs share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["160957"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["28497"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Beta-Drugs-Share-Price-Soared-17-on-Results-Day-After-Q1-FY27-Profit-Jumps-41-to-Rs-16.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=160935"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160935\/revisions"}],"predecessor-version":[{"id":160958,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/160935\/revisions\/160958"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/160957"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=160935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=160935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=160935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}